If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano:https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the reach and sight of children.
Do not use this medication after the expiration date that appears on the blister/packaging/container after CAD. The expiration date is the last day of the month indicated.
Do not store above25°C.
Blister packs: Store in the original packaging to protect the tablets from moisture. Bottles: Store in the original packaging and keep the bottle perfectly closed to protect the tablets from moisture.
Medicines should not be disposed of through drains or in the trash.Deposit the containers and medicines you no longer need at theSIGREpharmacy drop-off point. If in doubtask your pharmacist how to dispose of the containers and medicines you no longer need. By doing so, you will help protect the environment.
1OPADRY®contains:
hypromellose, macrogol, polisorbate 80, and as a coloring agent, titanium dioxide E171.
25 mg: white, rounded tablets, 6 mm in diameter, with the inscription "TOP" on one side and "25”on the other side.
Transparent plastic bottle with a child-resistant closure containing 20, 28, 30, 50, 56, 60, 100, or 200 (2x100) tablets. Each bottle includes a desiccant that should not be ingested.
Aluminum/aluminum blister pack. Package sizes: 10, 20, 28, 30, 50, 56, 60, 100, or 200 (2x100) tablets. Each blister pack (alu/alu) is contained within a protective bag.
Only some package sizes may be marketed.
JANSSEN-PHARMA, S.L.
Pº de las Doce Estrellas, 5-7
28042 Madrid
Spain
Responsible manufacturer
Janssen Pharmaceutica NV
Turnhoutseweg 30,
Belgium
or
Janssen-Cilag SpA
Via C. Janssen,
Borgo San Michele
04100
Latina
Italy
or
Lusomedicamenta – Sociedade Técnica Farmacêutica S.A.
Estrada Consiglieri Pedroso nº 69 B
Queluz de Baixo
2730-055 Barcarena
Portugal
This medicine is authorized in the member states of the European Economic Area with the following names:
Austria, Belgium, Cyprus, Czech Republic, Estonia, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain: | Topamax |
Denmark, Finland, Iceland, Norway, Sweden: | Topimax |
France: | Epitomax |
Greece: | Topamac |
Last review date of this leaflet:March 2024.
Other sources of information
The most recent approved patient guide information for this medicine is available by scanning the following QR code with a smartphone. The same information is also available on the following website (URL):
https://cima.aemps.es/cima/DocsPub/16/3252
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.